Oncology

TARGETED THERAPIES FOR CANCERS

COMPOUND INDICATION PRE – CLINICAL CLINICAL
TC-ONC-50
Chronic Myeloid Leukemia

TC-ONC-51
Gastrointestinal Stromal Tumors

TC-ONC-511
Kidney Cancer

TC-ONC-541
Acute Lymphoblastic Leukemia

We have modified the drug-delivery mechanism of certain kinase inhibitors to increase safety without compromising the intended beneficial behavior of these targeted therapies.
Hi, How Can We Help You?
error: Content is protected !!